Alternative protein products are often more expensive than traditional counterparts, but advancements in technology and ...

Kephart: We’re seeing a lot of development there. Rick Rieder came out with an active ETF on the fixed-income side, iShares ...

Achieving cost sustainability in inflammatory bowel disease (IBD) care requires expanding access to cost-effective treatments ...

Discover why ARTY struggles with high fees, poor performance, and increased risks. Learn why passive indices like QQQ ...

Mixing financial data with manufacturing analytics can boost efficiency, but there are still pockets of resistance.

Advanced transmission technologies could sidestep permitting challenges and clear the bottleneck holding up hundreds of ...